Literature DB >> 22401152

Medication adherence among recipients with chronic diseases enrolled in a state Medicaid program.

Rahul Khanna1, Patrick F Pace, Rohan Mahabaleshwarkar, Ram Sankar Basak, Manasi Datar, Benjamin F Banahan.   

Abstract

Limited information is currently available about medication adherence for common chronic conditions among the Medicaid population. The primary objective of this study was to assess medication adherence among Medicaid recipients with depression, diabetes, epilepsy, hypercholesterolemia, and hypertension. Factors influencing adherence were determined. The authors also assessed whether adherence influences the utilization of acute care services. The target population included nonelderly adult recipients (ages 21-64 years) who were continuously enrolled in the Mississippi (MS) Medicaid fee-for-service program from January 1, 2006 to December 31, 2007. Recipients were identified who had a medical services claim with a diagnosis of depression, diabetes, epilepsy, hypercholesterolemia, or hypertension in calendar year 2006. Within each chronic disease sample, medication adherence was determined using calendar year 2007 data for recipients who met inclusion and exclusion criteria. Recipients with adherence ≥80% were classified as adherent. Logistic regression analyses were used to determine the factors that predict medication adherence and the effect of adherence on concurrent all-cause acute care service (ie, hospitalization, emergency room visit) utilization. Approximately 24% of recipients with depression, 35.9% with diabetes, 53.6% with epilepsy, 32% with hypercholesterolemia, and 42.2% with hypertension were adherent. Within each chronic disease sample, males and whites had higher adherence than females and blacks. After controlling for demographic and disease-related covariates, recipients who were adherent had lower concurrent acute care service utilization than nonadherent recipients. Given the inverse relationship between adherence and acute care service utilization, policy makers should consider implementing educational interventions aimed at improving adherence in this underprivileged population.

Entities:  

Mesh:

Year:  2012        PMID: 22401152     DOI: 10.1089/pop.2011.0069

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  10 in total

1.  High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.

Authors:  Hu Zhang; Daniel M Frendl; Zongwei Wang; Aria F Olumi
Journal:  J Urol       Date:  2020-03-13       Impact factor: 7.450

2.  Psychosocial factors associated with medication adherence in ethnically and socioeconomically diverse patients with epilepsy.

Authors:  Amanda J Shallcross; Danielle A Becker; Anuradha Singh; Daniel Friedman; Rachel Jurd; Jacqueline A French; Orrin Devinsky; Tanya M Spruill
Journal:  Epilepsy Behav       Date:  2015-04-04       Impact factor: 2.937

3.  Development of an algorithm to link electronic health record prescriptions with pharmacy dispense claims.

Authors:  Megan Hoopes; Heather Angier; Lewis A Raynor; Andrew Suchocki; John Muench; Miguel Marino; Pedro Rivera; Nathalie Huguet
Journal:  J Am Med Inform Assoc       Date:  2018-10-01       Impact factor: 4.497

4.  Health Care Utilization After Paraprofessional-administered Substance Use Screening, Brief Intervention, and Referral to Treatment: A Multi-level Cost-offset Analysis.

Authors:  Jason Paltzer; David Paul Moberg; Marguerite Burns; Richard L Brown
Journal:  Med Care       Date:  2019-09       Impact factor: 2.983

5.  Social Risk Factors for Medication Nonadherence: Findings from the CARDIA Study.

Authors:  Gabriela R Oates; Lucia D Juarez; Barbara Hansen; Catarina I Kiefe; James M Shikany
Journal:  Am J Health Behav       Date:  2020-03-01

6.  Evaluation of medication adherence in chronic disease at a federally qualified health center.

Authors:  Alvin B Oung; Emily Kosirog; Benjamin Chavez; Jason Brunner; Joseph J Saseen
Journal:  Ther Adv Chronic Dis       Date:  2017-06-21       Impact factor: 5.091

7.  Changes in chronic medication adherence, costs, and health care use after a cancer diagnosis among low-income patients and the role of patient-centered medical homes.

Authors:  Lisa P Spees; Stephanie B Wheeler; Xi Zhou; Krutika B Amin; Christopher D Baggett; Jennifer L Lund; Benjamin Y Urick; Joel F Farley; Katherine E Reeder-Hayes; Justin G Trogdon
Journal:  Cancer       Date:  2020-08-11       Impact factor: 6.860

8.  Medication adherence in chronic illness: do beliefs about medications play a role?

Authors:  Jacinthe Lemay; Mohammad Waheedi; Sarah Al-Sharqawi; Tania Bayoud
Journal:  Patient Prefer Adherence       Date:  2018-09-05       Impact factor: 2.711

9.  Income and antiplatelet adherence following percutaneous coronary intervention.

Authors:  Anna R LaRosa; Gretchen M Swabe; Jared W Magnani
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-06-16

10.  Medication adherence and its determinants among psychiatric patients in an Ethiopian referral hospital.

Authors:  Zaid Demoz; Befikadu Legesse; Gebrehiwot Teklay; Birhanu Demeke; Tewodros Eyob; Zewdneh Shewamene; Mubarek Abera
Journal:  Patient Prefer Adherence       Date:  2014-09-25       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.